AB
WVE icon

Amalgamated Bank’s Wave Life Sciences WVE Stock Holding History

Amalgamated Bank’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,637
Closed -$62K – 2817
2025
Q4 		$62K Buy
3,637
+309
+9% +$3.14K ﹤0.01% 1783
2025
Q3 		$24K Hold
3,328
– – ﹤0.01% 2051
2025
Q2 		$22K Hold
3,328
– – ﹤0.01% 2082
2025
Q1 		$27K Buy
3,328
+828
+33% +$9.05K ﹤0.01% 1972
2024
Q4 		$31K Hold
2,500
– – ﹤0.01% 1975
2024
Q3 		$21K Hold
2,500
– – ﹤0.01% 2125
2024
Q2 		$12K Hold
2,500
– – ﹤0.01% 2368
2024
Q1 		$15K Sell
2,500
-2,658
-52% -$13.3K ﹤0.01% 2276
2023
Q4 		$26K Sell
5,158
-593
-10% -$3.17K ﹤0.01% 2544
2023
Q3 		$33K Hold
5,751
– – ﹤0.01% 2434
2023
Q2 		$21K Buy
+5,751
New +$23.2K ﹤0.01% 2732
2022
Q2 		– Sell
-7,218
Closed -$14K – 3217
2022
Q1 		$14K Buy
+7,218
New +$17.7K ﹤0.01% 2904

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Amalgamated Bank's WVE Position: Q1 2026 in Review

Amalgamated Bank sold out of Wave Life Sciences (WVE) in Q1 2026, closing a stake of 3,637 shares — an estimated $62K sold.

Amalgamated Bank first reported a position in WVE in Q1 2022 and held it in 12 quarters. The position peaked at $62K in Q4 2025. 231 funds tracked by Wall St. Rank hold WVE as of Q1 2026.

  • Amalgamated Bank reported no remaining Wave Life Sciences position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 3,637 Wave Life Sciences shares in Q1 2026, an estimated $62K.
  • Amalgamated Bank first reported a position in Wave Life Sciences in Q1 2022 and held it in 12 quarters.
  • Amalgamated Bank's Wave Life Sciences position peaked at $62K in Q4 2025.
  • 231 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.